352 filings
Page 5 of 18
424B5
5smg09e bkc
21 May 20
Prospectus supplement for primary offering
12:00am
424B5
jmz61bbm
19 May 20
Prospectus supplement for primary offering
4:12pm
8-K
lwa1ych4mm
7 May 20
VolitionRx Limited Announces First Quarter 2020 Financial Results and Business Update
4:19pm
8-K
crlew3dz3n u8oxpz
23 Apr 20
Volition Files Patent for Nu.QTM COVID-19 Triage Test and Commences Proof of Concept Studies
1:41pm
8-K
bbcid pjmmvk
20 Feb 20
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update
4:12pm
424B3
go4a83ugs2m1
18 Feb 20
Prospectus supplement
4:04pm
EFFECT
wpdsmt86 mb0
18 Feb 20
Notice of effectiveness
12:15am
CORRESP
jvk3 8exa5cucu201
13 Feb 20
Correspondence with SEC
12:00am
CORRESP
nw2x1 idn8rum55yi
13 Feb 20
Correspondence with SEC
12:00am
UPLOAD
u2guv4c6
13 Feb 20
Letter from SEC
12:00am
S-8
0vh3r6r1674m4u 71n4
7 Feb 20
Registration of securities for employees
5:28pm
8-K
76ue9 i2tepbmy8
12 Nov 19
VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update
4:12pm
8-K
0ez6e6 dhdyu1p3z
9 Oct 19
Volition Appoints Dr. Phillip Barnes to Board of Directors
4:15pm